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Original Investigation
Renal Morphology, Clinical Findings, and Progression Rate in
Mesoamerican Nephropathy
Julia Wijkstro¨m, MD,1 Marvin Gonza´lez-Quiroz, MD, MSc,2,3 Mario Hernandez, MD,4
Zulma Trujillo, MD,5 Kjell Hultenby, PhD,6 Anneli Ring, BS,7
Magnus So¨derberg, MD, PhD,7,8 Aurora Arago´n, MD, PhD,2
Carl-Gustaf Elinder, MD, PhD,1 and Annika Wernerson, MD, PhD1,7
Background: Mesoamerican nephropathy (MeN) is a chronic kidney disease affecting rural inhabitants in
Central America. We have previously described the renal morphology in 8 patients from El Salvador. To
confirm the renal pathology, we have studied kidney biopsies from patients with MeN in Nicaragua. Follow-up
urine and blood samples from both biopsy studies were collected to investigate the natural history.
Study Design: Case series.
Settings & Participants: In the kidney biopsy study, 19 male sugarcane workers in Nicaragua with sus-
pected MeN were investigated with questionnaires, kidney biopsies, and blood and urine analysis. Inclusion
criteria were age 20 to 65 years and plasma creatinine level of 1.13 to 2.49 mg/dL or estimated glomerular
filtration rate (eGFR) of 30 to 80 mL/min/1.73 m2. Exclusion criteria were proteinuria with protein excretion
. 3 g/24 h, uncontrolled hypertension, diabetes mellitus, or other known kidney disease. In the follow up-
study, blood and urine from the kidney biopsy study in Nicaragua (n 5 18) and our previous biopsy study of
MeN cases in El Salvador (n 5 7) were collected 1 to 1.5 and 2 to 2.5 years after biopsy, respectively.
Outcomes: Renal morphology, clinical, and biochemical characteristics, change in eGFR per year.
Measurements: eGFR was calculated using the CKD-EPI creatinine (eGFRcr), cystatin C (eGFRcys), and
creatinine-cystatin C (eGFRcr-cys) equations.
Results: In the kidney biopsy study, participants had a mean eGFRcr of 57 (range, 33-96) mL/min/1.73 m
2.
47% had low plasma sodium and 21% had low plasma potassium levels. 16 kidney biopsies were repre-
sentative and showed glomerulosclerosis (mean, 38%), glomerular hypertrophy, and signs of chronic
glomerular ischemia. Mild to moderate tubulointerstitial damage and mostly mild vascular changes were seen.
In the follow up-study, median duration of follow-up was 13 (range, 13-27) months. Mean change in eGFRcr
was 24.46 8.4 (range, 227.7 to 10.2) mL/min/1.73 m2 per year. Most patients had stopped working with
sugarcane cultivation.
Limitations: 3 biopsy specimens had 4 or fewer glomeruli.
Conclusions: This study confirms the renal morphology of MeN: chronic glomerular and tubulointerstitial
damage with glomerulosclerosis and chronic glomerular ischemia. Follow-up data show that eGFRs, on
average, deteriorated.
Am J Kidney Dis. 69(5):626-636. ª 2016 The Authors. Published by Elsevier Inc. on behalf of the National
Kidney Foundation, Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Mesoamerican nephropathy (MeN), an endemicform of chronic kidney disease (CKD), affects
rural inhabitants in Central America.1-3 Cross-
sectional studies in Nicaragua and El Salvador have
shown a high prevalence of CKD in villages near the
Paciﬁc coast, where agricultural work and other types
of manual labor are the main source of employ-
ment.4,5 Men working in sugarcane ﬁelds are often
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affected and the disease may progress to chronic
kidney failure, a devastating diagnosis in most
Central American countries, where the resources for
renal replacement therapy are limited. The cause
and pathogenesis of MeN are still not fully known,
but the extreme occupational conditions of the
sugarcane workers have made repeated dehydration
the leading hypothesis.6,7
Patients with MeN present with elevated creatinine
levels, no hypertension, and urine albumin levels are
normal or of non-nephrotic range. In 2012, we per-
formed the ﬁrst study on kidney biopsies and clinical
presentations of 8 agricultural workers in El Salvador
with MeN.8 We found a distinctive renal morphology
with widespread glomerulosclerosis and signs of
chronic glomerular ischemia, but only mild to mod-
erate tubulointerstitial changes. To conﬁrm these
ﬁndings in a larger cohort and in another area, we
have designed the present study in Nicaragua. To
examine the progression rate and possible prognostic
factors in MeN, we have collected follow-up blood
and urine samples from patients in the present biopsy
study and also from our previous biopsy study in El
Salvador.8
METHODS
Nicaragua Kidney Biopsy Study
Men with CKD of unknown cause and a history of sugarcane
work who had been to a medical visit at the Research Center of
Health, Work and Environment, National Autonomous University
of Nicaragua at León during a 12-month period were selected as
possible participants. Inclusion criteria were age 20 to 65 years and
plasma creatinine level of 100 to 220 mmol/L (1.13-2.49 mg/dL) or
estimated glomerular ﬁltration rate (eGFR) of 30 to 80 mL/min/
1.73 m2. Exclusion criteria were proteinuria with protein excretion
. 3 g/24 h, uncontrolled hypertension (blood pressure . 140/
90 mm Hg or .1 antihypertensive drug), diabetes mellitus (blood
glucose . 126 mg/dL), or other known kidney disease.
The study was performed in May 2014 (ie, after sugarcane
harvest season). Kidney biopsies and blood, urine, and clinical
data were collected. Ultrasound examinations of kidneys were
carried out before the biopsy. Participants answered questionnaires
(both open- and closed-ended questions) about employment (years
in different occupations); exposure to chemicals or pesticides (yes/
no); ﬂuid intake (volume and type of ﬂuid consumed); current
medicine use and estimation of weekly intake of nonsteroidal anti-
inﬂammatory drugs (NSAIDs), acetaminophen, and other analge-
sics during different periods in their lifetime; smoking habits (past
or current smoking); and if they had ever fainted at work (yes/no).
Blood and Urine Samples
Within 1 week prior to the kidney biopsy procedure, blood and
urine samples were collected and analyzed at the laboratory of the
faculty of medicine at National Autonomous University of
Nicaragua at León for hepatitis B and C virus, hematocrit, white
blood cell count, international normalized ratio, activated partial
thromboplastin time, and urine dipstick, sediment, culture, and
24-hour protein.
At the morning of the biopsy, new blood and urine samples were
collected and stored at 220C for 1 to 4 days, then shipped on dry
ice to Karolinska Institutet and stored at 270C. At Karolinska
University Hospital Laboratory (KUHL), plasma was analyzed for
creatinine, cystatin C, potassium, sodium, uric acid, calcium,
albumin, alanine aminotransferase, antineutrophil cytoplasmic
antibody and antinuclear antibody screening, anti2glomerular
basement membrane (GBM) antibodies, and complement. Urine
was analyzed for albumin, creatinine, uric acid, sodium, potassium,
N-acetyl-b-D-glucosaminidase (NAG), and a1-microglobulin. All
analyses were performed according to standard protocols. The
creatinine and cystatin C assays used were isotope-dilution mass
spectrometry (IDMS) traceable. Urine arsenic, cadmium, mercury,
and lead were analyzed with inductively coupled plasma mass
spectrometry according to US Environmental Protection Agency
methods 200.89 at ALS Scandinavia AB Laboratory, Luleå,
Sweden. When calculating mean values, urinary values below the
lower limits of detection were imputed as one-half the lower limit of
detection value; albumin , 3.0 mg/L was converted to 1.5 mg/L;
NAG , 0.5 nkat/L, to 0.25 nkat/L; a1-microglobulin , 6 mg/L, to
3 mg/L; cadmium, 0.05 mg/L, to 0.025 mg/L;mercury, 0.2 mg/L,
to 0.1 mg/L, and lead , 0.5 mg/L, to 0.25 mg/L. eGFR was calcu-
lated using the CKD-EPI (CKD Epidemiology Collaboration)
equations for creatinine (eGFRcr), cystatin C (eGFRcys), and crea-
tinine2cystatin C (eGFRcr-cys).
10,11 Reference values are presented
in the tables and were according to KUHL, except for plasma
potassium and uric acid (from the Nicaragua laboratory). For urine
heavy metal reference range, see references 12 and 13.
Kidney Biopsies
Percutaneous ultrasound-guided kidney biopsies were per-
formed at Hospital La Fraternidad, ﬁlial San José, using a spring-
loaded needle (16 Ga Biocore II MG/DANA 2.2 MG; Histo). After
the biopsy, patients stayed for 24-hour observation. Biopsy spec-
imens were divided and prepared according to standard protocols
for light microscopy, immunoﬂuorescence, and electron micro-
scopy (for details see Item S1, available as online supplementary
material). De Galantha staining was performed on parafﬁn-
embedded tissue to detect urate crystals.14
Two senior consultants in renal pathology (A.W. and M.S.) did
individual evaluations of the renal morphology followed by a
discussion to reach consensus.
Biopsy specimens with 10 or more glomeruli were rated as
representative; 7 to 9 glomeruli, as marginally representative; and
fewer than 7 glomeruli, as not representative. Grading of tubular
atrophy, interstitial inﬂammation, and interstitial ﬁbrosis in the
cortical area were deﬁned as follows: mild, affecting ,25% of the
area; moderate, affecting 26% to 50%; and severe, affecting
.50%.15 Glomerular hypertrophy and vascular pathology were
graded semiquantitatively as no/normal, mild, moderate, or severe.
Podocyte foot-process effacement was semiquantiﬁed by
calculating the number of slits per micron of GBM in 5 random
capillaries per glomerulus. Effacement was deﬁned as
widespread, $80% of measured areas with ,1.0 slit/mm GBM, or
segmental, 21% to 79% of evaluated areas with ,1.0 slit/mm
GBM.
Follow-up of El Salvador Biopsy Study
Seven of 8 patients from our previous kidney biopsy study in El
Salvador8 were followed up with blood and urine sampling 19 to
26 months after kidney biopsy. Samples were collected in May
through July (ie, after harvest season). Four samples were trans-
ported to KUHL and analyzed for plasma creatinine (IDMS
traceable), sodium, and potassium. Three samples were analyzed
at Hospital Rosales, San Salvador, with a creatinine assay not
traceable to IDMS. eGFRcr was calculated. When calculating
change in eGFRcr, baseline samples from the same laboratory were
used. One patient had initiated hemodialysis therapy; creatinine
analyzed before dialysis therapy initiation was used as follow-up.
One patient was lost to follow-up.
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Follow-up of Nicaragua Kidney Biopsy Study
Of 19 patients, 18 were followed up with blood and urine
sampling 13 to 17 months after the biopsy. Samples were collected
in June or October (ie, outside of harvest season). Samples were
analyzed at KUHL for plasma creatinine (IDMS traceable), so-
dium, potassium, uric acid, and cystatin C (IDMS traceable) and
urine albumin, creatinine, and a1-microglobulin. eGFRcr, eGFRcys,
and eGFRcr-cys were calculated. One patient (patient 14) was lost
to follow-up.
Ethics Statement
Ethics committees in Stockholm, Sweden (2012/441-31/3;
2013/1225-32; 2015/849-32), at the National Autonomous Uni-
versity of Nicaragua at León (ACTA No 83, 2013; ACTA No 31,
2015), and at the Hospital Nacional Rosales, San Salvador, El
Salvador (ACTA No 03, 2012; ACTA exp No 11, 2016) approved
the study. All participants have given informed consent.
Statistical Analysis
In the follow-up study, simple linear regression was calculated
to predict change in eGFRcr per year based on biochemical data at
baseline. Morphology associations were calculated using unpaired
t test comparing mean change in eGFRcr per year between groups
with different morphology; patients with not representative bi-
opsies (Nicaragua patients 4 and 11) were excluded.
RESULTS
Nicaragua Kidney Biopsy Study
There were 100 possible participants identiﬁed, 50
of whom matched the inclusion/exclusion criteria and
were invited to participate. Twenty patients did not
answer and 11 declined. Thus, 19 patients agreed and
were included in the study. All participating patients
had normal blood pressure 1 week prior to the biopsy.
Questionnaires
Exposure and clinical data are presented in Table 1.
All patients had previously been working with sug-
arcane cultivation for 2.5 to 38 years. Work tasks
were mainly cane cutting, irrigation, and seeding.
Regular NSAID and acetaminophen use (deﬁned as
weekly use for $2 years) was reported from 32% and
53% of patients, respectively. There were 47% who
reported no regular use of analgesic. Mean self-
reported liquid intake for a workday was 9.0 (range,
3.4-15.1) L, and mean current daily liquid intake was
5.3 (range, 1-10) L. Water was the main liquid
consumed (77% workdays, 72% of current liquids).
Soda and fruit juice were 11% of the intake for
workdays and 25% of the current intake. All but 2
patients used electrolyte solutions during the workday
(mean, 11% of liquids consumed).
Blood Tests
Results of most analyses are presented in Table 2.
Alanine aminotransferase level was elevated in 1
patient. Serum osmolality was elevated in 3 patients,
at 304, 304, and 316 mOsm/L. Renin level was
elevated in 8 patients; in these patients, mean sodium
level was 136 (range, 135-137) mEq/L, 3 had
hypokalemia, and all 8 had aldosterone levels within
the reference range. In patient 1, aldosterone and
aldosterone/renin levels were elevated, at 1,080 pmol/
L and 60 pmol/mIU, respectively. All patients had
plasma glucose, calcium, and phosphate levels within
the reference ranges and had negative screening re-
sults for hepatitis B and C virus and human immu-
nodeﬁciency virus (HIV). No antineutrophil
cytoplasmic or anti-GBM antibodies were found.
Complement levels showed no signs of activation.
Antinuclear antibody screening with immunoﬂuores-
cence was positive in patient 13; subsequent analysis
for double-stranded DNA antibodies, centromere an-
tibodies, and extractable nuclear antigens gave nega-
tive results.
Urine Tests
Results regarding urinary biomarkers and heavy
metals are presented in Table 3. Two of the 4 patients
with hypokalemia had urine potassium excretion
. 40 mEq/L and all 4 hypokalemic patients had urine
potassium-creatinine ratios . 1.5 mEq/mmol, indi-
cating renal potassium losses.16 In the 9 patients with
low plasma sodium levels, mean urine sodium
excretion was 88.66 51.6 (range, 21-172) mEq/L.
Dipstick showed no hematuria, leukocytes, or
Table 1. Nicaragua Biopsy Study: Clinical Characteristics and
Questionnaire Data at Time of Kidney Biopsy
Characteristic Value
Age, y 33 6 8 (24-54)
BMI, kg/m2 25 6 4 (19-37)
Systolic BP, mm Hg 1216 8 (105-133)
Diastolic BP, mm Hg 75 6 7 (56-88)
Kidney length, mm 91 6 8 (74-104)
Duration of sugarcane work,a y 12 6 8 (2.5-38)
Duration as sugarcane cutter, y 7 6 7 (0-26)
Duration of agricultural work,b y 15 6 10 (3-40)
Antihypertensive medicine 0 (0)
Antibiotics past 6 mo 0 (0)
Regular long-time NSAID usec 6 (32)
Current NSAID use 4 (21)
Current acetaminophen use 7 (37)
Herbal medicine use 1 (5)
Ever fainted at work 7 (37)
Exposure to chemicals/pesticides 7 (37)
Current smoking 0 (0)
Past smoking 6 (32)
Alcohol consumption 4 (21)
Note: n 5 19. Values for categorical variables are given as
count (percentage); for continuous variables, asmean6 standard
deviation (range).
Abbreviations: BMI, body mass index; BP, blood pressure;
NSAID, nonsteroidal anti-inflammatory drug.
aDefined as work at sugarcane plantation.
bAgricultural work including sugarcane work and other
agricultural work.
cUse of 1 to 2 or more tablets per week during 2 years or
longer.
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glucosuria; dipstick protein was increased in 2 pa-
tients (trace and 31, respectively). Sediment showed
no casts. Patients 7 and 15 had increased urinary
albumin-creatinine ratios at 316 and 809 mg/g,
respectively.
Kidney Biopsies
All 19 participants underwent kidney biopsy. One
participant developed transient macroscopic hematu-
ria; the other participants had no adverse events.
Light Microscopy and Immunoﬂuorescence
Overview
There were 13 biopsy specimens that were repre-
sentative; 3, marginally representative; and 3, not
representative. Polarized light on parafﬁn-embedded
tissue detected no crystals. No uric acid crystals
were found using de Galantha staining. In 9 patients,
frozen tissue was available for evaluation
with polarized light; in 1 patient (patient 12), 1
round-shaped crystal was seen. Evaluation of the
representative and marginally representative biopsy
specimens (n 5 16) are presented in the following
text and Table 4. Information about the not repre-
sentative biopsies (n 5 3) is presented in Table S1.
Glomerular Changes
Specimens showed global glomerulosclerosis of
varying proportions, 7% to 70%, and hypertrophy of
the remaining glomeruli (Fig 1A). In patients 7 and
15, glomerular segmental sclerosis were found.
Discrete mesangial matrix expansion was seen in
most patients, but no mesangial cell proliferation.
Focal wrinkling of the GBM and/or periglomerular
ﬁbrosis was seen in all but 1 patient (Fig 1A, C, and
D). In 4 patients, no representative material for
immunoﬂuorescence was collected due to limited
biopsy material. In the other patients, immunoﬂuo-
rescence showed no signs of immune complex
disease.
Table 2. Nicaragua Biopsy Study: Blood Tests at
Time of Biopsy
Variable Mean 6 SD (Range)
eGFRcr-cys, mL/min/1.73 m
2 56 6 18 (36-96)
eGFRcr, mL/min/1.73 m
2 57 6 18 (33-96)
eGFRcys, mL/min/1.73 m
2 57 6 20 (38-109)
Plasma
Creatinine, mg/dL 1.66 6 0.38 (1.04-2.51)
Cystatin C, mg/L 1.47 6 0.31 (0.85-1.89)
Potassium, mEq/L 3.8 6 0.6 (2.2-4.9)a
Sodium, mEq/L 1376 2 (133-139)b
Magnesium, mEq/L 1.41 6 0.22 (1.02-1.64)c
Uric acid, mg/dL 7.45 6 2.02 (4.44-12.02)d
Renin, mIU/L 68 6 134 (18-650)
Aldosterone, pmol/L 265 6 217 (86-1,080)
Aldosterone-renin ratio, pmol/mIU 9.56 13.0 (0.3-60)
Albumin, g/dL 4.4 6 0.3 (3.8-5.1)
Alanine aminotransferase, U/L 31 6 33 (3-151)
Serum osmolality, mOsm/kg 2966 7 (288-316)
Note: n 5 19. Reference values: eGFR, .90 mL/min/1.73 m2;
creatinine,,1.13 mg/dL; cystatin C,,0.99 mg/L; potassium, 3.5
to 5.0 mEq/L; sodium, 137 to 145 mEq/L; magnesium, 1.4 to 1.9
mEq/L; uric acid, 3.0 to 7.0 mg/dL; osmolality, 280 to 300 mOsm/
kg; renin, 2.8 to 40 mIU/L; aldosterone, ,650 pmol/L; albumin,
3.6 to 4.5 g/dL; alanine aminotransferase, ,72 U/L; and aldo-
sterone to renin ratio, ,60 pmol/mIU. Conversion factors for
units: creatinine in mg/dL to mmol/L, 388.4; magnesium in mEq/
L to mmol/L, 30.5; uric acid in mg/dL to mmol/L, 359.48; alanine
aminotransferase in U/L to mkat/L, 30.0167.
Abbreviations: eGFRcr, estimated glomerular filtration rate
based on creatinine; eGFRcr-cys, estimated glomerular filtration
rate based on creatinine and cystatin C; eGFRcys, estimated
glomerular filtration rate based on cystatin C; SD, standard
deviation.
aFour (21%) patients had plasma potassium ,3.5 mEq/L.
bNine (47%) patients had plasma sodium ,137 mEq/L.
cSeven (37%) patients had plasma magnesium ,1.4 mEq/L.
dEleven (58%) patients had plasma uric acid .7.0 mg/dL.
Table 3. Nicaragua Biopsy Study: Urine Test Results at
Time of Biopsy
Urine Variable Mean 6 SD (Range)
Culture All negative
Potassium, mEq/L 33 6 17 (4-61)
Potassium-creatinine ratio,
mEq/mmol
4.2 6 1.3 (2.7-8.9)
Sodium, mEq/L 1196 59 (21-254)
pH 6.26 0.4 (6-7)
24-h urine volume, L 3.16 1.4 (1.3-6.7)a
ACR, mg/g 64 6 194 (0.8-809)b
NAG-creatinine ratio, nkat/g 68 6 53 (5-186)c
A1M-creatinine ratio, mg/g 27 6 33 (3-141)d
Arsenic, mg/L 10.3 6 6.6 (1.31-20.1)
Cadmium-creatinine ratio, mg/g 0.106 0.09 (0.02-0.336)e
Mercury-creatinine ratio, mg/g 0.326 0.25 (0.05-0.88)f
Lead-creatinine ratio, mg/g 0.98 6 0.88 (0.15-2.93)g
Note: n5 19. Reference values: 24-hour urine volume, 0.5 to
3 L; ACR, ,30 mg/g; NAG-creatinine ratio, ,71 nkat/g; A1M-
creatinine ratio, ,6.2 mg/g; arsenic, ,100 mg/L; cadmium-
creatinine ratio, ,2 mg/g; mercury-creatinine ratio, ,5 mg/g;
and lead-creatinine ratio, ,50 mg/g. Conversion factors for units:
ACR in mg/g to mg/mmol, 30.113; NAG-creatinine ratio in nkat/
g to nkat/mmol, 30.113; A1M-creatinine ratio in mg/g to mg/
mmol, 30.113.
Abbreviations: A1M, a1-microglobulin; ACR, albumin-
creatinine ratio; NAG, N-acetyl-b-D-glucosaminidase; SD, stan-
dard deviation.
aNine (47%) patients had 24-hour urine volume .3 L.
bTwo (11%) patients had ACRs.30 mg/g.
cEight (42%) patients had NAG-creatinine ratio . 71 nkat/g.
dThirteen (68%) patients had A1M-creatinine ratios .
6.2 mg/g.
eEight (42%) patients had no detectable urinary cadmium
(ie, ,0.05 mg/L).
fTen (53%) patients had no detectable urinary mercury
(ie, ,0.2 mg/L).
gTen (53%) patients had no detectable urinary lead
(ie, ,0.5 mg/L).
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Tubulointerstitial Changes
Interstitial ﬁbrosis was mild to moderate (Fig 1B) in
most patients. Interstitial inﬂammation was generally
mild, located in ﬁbrotic areas, and consisting of
lymphocytes. A few neutrophil granulocytes were
found in tubuli of 2 patients. In 2 patients, a few
eosinophils were found in the interstitium. Mild
tubular atrophy was common (Fig 1C and D). Mild
tubulitis was seen in 1 patient.
Vascular Changes
Arteries were found in all but 1 patient. Arterial
changes were generally mild (Fig 1C and D; Table 4).
Five specimens showed arteriolar hyalinosis (mild in
3 patients, moderate in 2).
Electron Microscopy
Results are presented in Tables 4 and S2. No im-
mune deposits were found. Mild thickening of the
GBM due to homogenous thickening of the lamina
densa was seen in 5 patients. The podocytic cyto-
plasm often contained vacuoles (Fig 2A) or
lipofuscin-like bodies (Fig 2B). Cell debris, probably
derived from podocytes, was seen between capillary
loops in Bowman’s space in 3 patients (Fig 2C). The
parietal epithelial cells of Bowman’s capsule dis-
played no apparent pathology. Podocytic foot-process
effacement was seen in 9 patients (Fig 2D). The
endothelium was mostly normal, but in 6 patients, it
was swollen at varying degrees (Fig 2D). In 4 pa-
tients, the swollen endothelium also showed reduced
fenestration. Tubular structures showed varying
Table 4. Nicaragua Biopsy Study: Light and Electron
Microscopy Findings of Representative and Marginally
Representative Biopsies
Microscopy Findings Value
Light microscopy findings (n5 16)
Glomerular changes (n5 16)
Mean globally sclerosed glomeruli 38% 6 21%
(7%-70%)
Percentage globally sclerosed glomeruli
,25% 4 (25%)
25%-50% 7 (44%)
.50% 5 (31%)
Segmental scleroses 2 (12.5%)
Glomerular hypertrophy
0 0 (0%)
1 0 (0%)
2 11 (69%)
3 5 (31%)
Wrinkled GBM/periglomerular fibrosis
Yes 15 (94%)
No 1 (6%)
Tubulointerstitial changes (n 5 16)
Tubular atrophya
0 1 (6%)
1 13 (81%)
2 2 (13%)
3 0 (0%)
Interstitial fibrosisa
0 1 (6%)
1F 8 (50%)
2F 7 (44%)
3F 0 (0%)
Interstitial inflammationa
0 2 (13%)
1 12 (75%)
2 2 (13%)
3 0 (0%)
Vascular changes (n 5 15)
Intimal thickening
0 11 (73%)
1 3 (20%)
2 1 (7%)
3 0 (0%)
Smooth muscle hyperplasia
0 5 (33%)
1 6 (40%)
2 4 (27%)
3 0 (0%)
Electron microscopy findings (n 5 16)
GBM thickness, nmb 4416 63
(333-566)c
Podocyte foot processes, slits/mm GBM 1.06 0.5
(0.1-1.7)
Podocyte foot process effacementd
No (normal) 7 (44%)
Segmental effacement 4 (25%)
Widespread effacement 5 (31%)
Endothelial cells
Normal 10 (62%)
Swollen 6 (38%)
Podocyte cytoplasm inclusions
Yes 12 (75%)
No 4 (25%)
Table 4 (Cont’d). Nicaragua Biopsy Study: Light and Electron
Microscopy Findings of Representative and Marginally
Representative Biopsies
Microscopy Findings Value
Immune complex deposits
Yes 0 (0%)
No 16 (100%)
Note: Values are given as cases (percentage) or mean 6
standard deviation (range). Mean number of glomeruli (n 5 16):
17 6 7 (7-28). Grading: 0, normal; 1, mild; 2, moderate; and 3,
severe.
Abbreviations: F, focal; GBM, glomerular basement
membrane.
aGrading of tubular atrophy, interstitial inflammation, and
interstitial fibrosis is defined as 15mild, affecting,25% of area;
2 5 moderate, affecting 26% to 50%; and 3 5 severe, affecting
.50%.
bGBM thickness normal range, 250 to 457 nm.
cFive (31%) patients had thickened GBM.
dPodocyte foot-process effacement defined as
widespread, $80% of evaluated areas with ,1.0 slit/mm GBM;
segmental, 21%-79% of evaluated areas with ,1.0 slit/mm
GBM.
630 Am J Kidney Dis. 2017;69(5):626-636
Wijkstro¨m et al
degrees of tubular atrophy, but otherwise no apparent
pathology.
Follow-up of El Salvador and Nicaragua Biopsy
Studies
In total, 25 of 27 participants in the 2 biopsy studies
were included in the follow-up, and they had a mean
change in eGFRcr per year of 24.46 8.4
(range, 227.7 to 10.2) mL/min/1.73 m2.
El Salvador Follow-up
Seven of 8 patients were followed up 19 to 26
months after kidney biopsy (Table 5). One patient had
initiated hemodialysis therapy after 19 months (with
eGFRcys of 9 mL/min/1.73 m
2 3 days before dialysis
therapy initiation). Urine samples were available for 5
patients; 2 had increased urine albumin-creatinine ra-
tios (2,458 and 45 mg/g). Two patients were working
with sugarcane, 4 with other agricultural work, and 1
was unemployed.
Nicaragua Follow-up
Eighteen of 19 patients were followed up 13 to 17
months after kidney biopsy (Table 5). Urine
albumin-creatinine ratioswere increased in patients 7 and
19 (462 and 2,270 mg/g). Ten patients were unemployed
or on pension; 2, construction workers; 1, an agricultural
worker (not sugarcane); 1, a baker; 1, a mechanic; and 3,
in non–physically strenuous professions.
Possible Predictors of Decrease in eGFR
Simple linear regression was performed to predict
change in eGFRcr based on various biochemical data at
the time of the biopsy (t0); results are presented in
Table S3. A signiﬁcant correlation was seen between
plasma sodium level and change in eGFRcr per year
when combining both cohorts (El Salvador and
Nicaragua, n5 25). Introducing baseline eGFR as a
covariate in the equation did not signiﬁcantly (P5 0.7)
inﬂuence the decline in eGFR related to plasma sodium
Figure 1. Light microscopy findings in kidney tissue from the Nicaragua biopsy study. Global glomerulosclerosis of varying degree
(stars in A [periodic acid–Schiff (PAS)-methenamine staining from patient 1], B [Ladewig staining from patient 9], and D [PAS staining
from patient 9]) and (A, B) moderate to severe glomerular hypertrophy (black arrow) were found in all patients. Signs of glomerular
ischemia with thickening of Bowman’s capsule or wrinkling of capillary walls (arrowheads in A, C [PAS staining from patient 6], and
D) were found in all but 1 patient. (B) Mild to moderate interstitial fibrosis (white arrow) and (C, D) tubular atrophy of varying degree
(black arrows) were seen in most patients. (C, D) Arteries were in most cases normal (white arrows) or only mildly changed. Scale
bars 5 (A, C) 100 mm, (B, D) 200 mm.
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level (P5 0.02). Therefore, baseline eGFR was not
used as a covariate in any of the calculations in Table S3.
Patients with severe glomerular enlargement had a
signiﬁcantly larger decrease in eGFRcr compared with
patients with mild to moderate enlargement
(Table S4).
DISCUSSION
This unique study describes the renal morphology
and biochemical characteristics of 19 patients with
MeN in Nicaragua and also presents 1- to 2-year
follow-up data from this cohort, as well as from our
previous biopsy study of 8 patients with MeN in El
Salvador.
The renal morphology shows glomerulosclerosis of
varying degrees, glomerular hypertrophy, and signs of
chronic glomerular ischemia, together with mild to
moderate chronic tubulointerstitial damage. The
morphology is very similar to ﬁndings in our previous
study of MeN cases.8
Figure 2. (A) Transmission electron microscopy image from patient 10 shows cytoplasm of a podocyte (pc) containing vacuoles
(arrowhead). (B) Image from patient 17 shows lipofuscin-like bodies (lflb) in cytoplasm of a podocyte. (C) Image from patient 6 shows
cell debris in Bowman’s space (*), probably derived from podocytes because it was mostly found within the glomerular tuft between
capillary loops and Bowman’s capsular epithelium showed no apparent pathology. (D) Image from patient 17 shows widespread
foot-process effacement (arrowhead) and a focally swollen endothelium (*). Abbreviations: c, capillary space; n, nucleus. Scale
bars 5 (A) 5 mm, (B-D) 1 mm.
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We used similar inclusion and exclusion criteria as
in our previous biopsy study, but this study included
twice as many patients, enabling a more detailed
description of the disease. Furthermore, eGFRcr-cys in
this study is higher (mean, 56 compared to 42 mL/
min/1.73 m2) and participants are younger (mean,
33 compared to 44 years), thus reducing possible
age-related morphologic changes and describing
earlier lesions in MeN.
Chronic glomerular changes were seen in all patients.
Glomerular hypertrophy was present in all patients and
could be the result of compensatory mechanisms due to
nephron loss/low nephron count or chronic
ischemia.17,18 In all but one patient, wrinkling of the
GBM and/or periglomerular ﬁbrosis was seen. These
changes, indicating glomerular ischemia, are often
found in nephrosclerosis,19 but neither hypertension nor
vascular changes consistent with hypertension were
found. Immune complex glomerulonephritis could be
excluded in all representative biopsies by immunoﬂuo-
rescence or electron microscopy.
The chronic tubulointerstitial damage was in most
cases mild and in some cases was moderate. Signs of
tubular damage were also evident in urine, in which
NAG or a1-microglobulin levels often were elevated.
A few granulocytes were found in tubuli of 2 patients,
but because urine culture results were negative, acute
pyelonephritis is unlikely. Chronic pyelonephritis is
more difﬁcult to exclude. However, in a previous
report, urine cultures from 103 sugarcane workers all
gave negative results, indicating that infections are
uncommon.20
Podocyte foot-process effacement was found in 9
of 16 patients, but was not correlated to albuminuria
because only 1 of these patients displayed albumin-
uria. Other signs of podocytic injury, including
podocyte debris and lipofuscin-like bodies, were also
found. Whether there is primary damage to the
podocytes or secondary damage due to glomerular
hypertrophy is unclear.
In 2014, López-Marín et al21 published a study of
kidney biopsies from 46 Salvadoran patients with
eGFRs of 30 to 89 mL/min/1.73 m2. They
concluded that their main ﬁnding was “chronic
tubulointerstitial nephropathy” with subsequent
glomerular and vascular damage. However, they
also reported that 67% of the men in the study had
.25% global glomerulosclerosis and 83% of the
men had ,25% tubular atrophy (ie, results similar to
our ﬁndings).
Based on our previous study, others have described
the morphology of MeN as “chronic tubulointerstitial
nephropathy with secondary glomerular damage.”22
We do not agree with this phrase because we
would describe the morphology as a combination of
chronic glomerular and tubulointerstitial changes for
which the mechanism has to be elucidated. That
tubulointerstitial damage can cause glomerular dam-
age or vice versa is well known.23 In our experience,
the ratio between the glomerular and cortical
tubulointerstitial damages found in our studies of
MeN suggest that the tubulointerstitial damage alone
might not be enough to explain the glomerular
changes.
Table 5. Follow-up Plasma and Urine Data From El Salvador and Nicaragua Kidney Biopsy Studies
El Salvador Biopsy (n 5 7) Nicaragua Biopsy (n 5 18)
Postbiopsy follow-up time, mo 25 6 3 (19-27) 14 6 2 (13-17)
eGFRcr, mL/min/1.73 m
2 45 6 25 (9 to 76) 52 6 20 (20 to 87)
DeGFRcr, mL/min/1.73 m
2 per y 23.6 6 5.2 (213.3 to 2.8) 25.36 9.2 (227.7 to 10.2)
eGFRcr-cys, mL/min/1.73 m
2 48 6 20 (18 to 85)
DeGFRcr-cys, mL/min/1.73 m
2 per y 27.06 8.2 (224.9 to 6.5)
Plasma
Potassium, mEq/L 3.3 6 0.7 (1.9 to 4)a 4.36 0.6 (2.8 to 4.8)b
Sodium, mEq/L 1326 4 (126 to 136) 138 6 1 (135 to 140)b
Uric acid, mg/dL — 7.30 6 2.52 (4.12 to 12.19)b
Urine
ACR, mg/g 508 6 1,091 (4 to 2,458)a 1556 539 (1 to 2,270)b
NAG:Cr ratio, nkat/g 1086 46 (53 to 168)a
A1M:Cr ratio, mg/g - 24 6 34 (4.5 to 144)b
Note: Values are given as mean 6 standard deviation (range). Reference values: potassium, 3.5 to 5.0 mEq/L; sodium, 137 to 145
mEq/L; uric acid, 3.0 to 7.0 mg/dL; ACR, ,30 mg/g; NAG:Cr ratio, ,71 nkat/g; A1M/Cr ratio, ,6.2 mg/g. To convert uric acid in mg/dL
to mmol/L, 359.48.
Abbreviations: A1M, a1-microglobulin; ACR, albumin-creatinine ratio; Cr, creatinine; eGFRcr, estimated glomerular filtration rate
based on creatinine; eGFRcr-cys, estimated glomerular filtration rate based on creatinine and cystatin C; NAG, N-acetyl-b-D-
glucosaminidase.
aPotassium was ,3.5 mEq/L in 4 patients; ACR, .30 mg/g in 2 patients; and NAG:Cr ratio, .71 nkat/g in 4 patients.
bPotassium was,3.5 mEq/L in 2 patients; sodium,,137 mEq/L in 4 patients; uric acid,.7.0 mg/dL in 7 patients; ACR,.30 mg/g in
2 patients; and A1M:Cr ratio, .6.2 mg/g in 11 patients.
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The ﬁnding of low plasma sodium, potassium, and
magnesium levels in many patients (Tables 2 and 5)
is striking. Spot urine samples suggest that the hy-
pokalemic patients in our Nicaraguan cohort have
renal potassium losses, a ﬁnding that also has been
reported from another MeN study.24 Interestingly,
when combining data from both biopsy cohorts, low
sodium at baseline was correlated with a higher
progression rate (Table S3). To establish if this is a
correlation or causation, further studied in larger co-
horts are needed. Hyponatremia correlated to sugar-
cane work,25 as well as extreme exercise,26,27 has
been described, but our study was performed outside
of harvest season, indicating a chronic state inde-
pendent from the extreme conditions during sugar-
cane harvest. The participants’ large urine volumes
(mean, 3.1 L/24 h) are noteworthy. Excessive water
intake may contribute to the hyponatremia in some
patients. We have previously argued for possible
renin-angiotensin-aldosterone system activation as
one of the mechanisms behind the glomerular
ischemia and hypokalemia seen in MeN.8 Our ﬁnd-
ings further support the hypothesis that chronic
sodium depletion may stimulate the renin-
angiotensin-aldosterone system, whereby angio-
tensin II would cause glomerular ischemia by
constriction of glomerular capillaries and aldosterone
would cause hypokalemia. Plasma renin level was
increased in 8 patients, who also were low or in the
lower reference range for plasma sodium. However,
aldosterone levels were in most cases within the
reference ranges, making the data difﬁcult to inter-
pret. Analysis of renin, angiotensin II, and aldoste-
rone during harvest would be of great interest.
To our knowledge, this is the ﬁrst report presenting
follow-up data from patients with kidney
biopsy2veriﬁed MeN. Our data show a mean decline
in eGFRcr of 4.4 mL/min/1.73 m
2 per year. However,
individual variation in change in eGFR over time was
great (Table 5).
When comparing kidney morphology with pro-
gression rate, we found that patients with severe
glomerular hypertrophy had a worse prognosis
(Table S4). This ﬁnding needs to be conﬁrmed in
larger studies.
The cause of MeN is not fully understood, but the
leading hypothesis is occupational heat exposure with
repeated episodes of volume and salt depletion.6,28,29
That volume depletion can lead to acute kidney injury
(AKI) is known, and in recent years, AKI has been
found to be a risk factor for CKD development.30,31
Three studies of sugarcane workers report increasing
serum creatinine levels of about 10% to 20% after a
workday,25,29,32 supporting the hypothesis that
repeated AKI caused by extreme working conditions
may be the major cause of MeN.
Interestingly, a morphologic picture similar to that
of MeN has been described in rats developing CKD
after AKI.33-35 Kidney morphology 9 months after
ischemic AKI is described as glomerular hypertrophy,
glomerulosclerosis, podocyte foot-process effacement,
and tubulointerstitial damage. Furthermore, rats
developing CKD after AKI were normotensive,
another similarity with patients with MeN. Spi-
ronolactone and losartan treatment prevented the
development of CKD, suggesting that these agents,
affecting the renin-angiotensin-aldosterone system, are
of importance in the pathophysiology.
A possible mechanism for developing CKD due to
repeated dehydration involving fructose metabolism
in tubuli has been presented in a study of mice.36 The
authors suggest the main pathologic mechanism to be
tubular damage caused by end products in the fructose
metabolism (inﬂammatory mediators, oxidants, and
uric acid). Hyperuricemia and hyperuricosuria have
also been hypothesized as possible mechanisms.37 In
our study, we did not ﬁnd support for uric acid ne-
phropathy; no uric acid crystals or lesions related to
hyperuricemia were seen. However, we cannot
exclude the possibility because biopsies were not
performed during dehydration.
The role of NSAIDs in the development of MeN has
been discussed.1,38 In the present study, most Nicar-
aguan participants did not use NSAIDs. However, the
pharmacodynamic properties of NSAIDs, reducing
renal blood ﬂow, are probably harmful in MeN, in
which glomerular ischemia is already present.
Heavy metals have been raised as possible co-
factors in MeN development.39 In this study, we
could not ﬁnd evidence for this because all values
were below toxic levels.12,13,40
In recent years, the resemblance between MeN and
CKD of unknown origin affecting rural inhabitants in
Sri Lanka has been discussed.38,41 Tubulointerstitial
damage has been described as the main lesion in
kidney biopsy specimens, but glomerulosclerosis,
glomerular enlargement, and thickening of Bowman’s
capsule have also been reported,42,43 indicating a
resemblance with MeN. Most biopsy studies in Sri
Lanka have included participants by screening for
proteinuria, and this makes comparison difﬁcult
because patients with MeN often lack proteinuria.
In summary, we propose that the ﬁndings in our
study are compatible with the hypothesis that MeN is
caused by recurrent kidney injury due to occupational
heat stress with subsequent volume and salt depletion.
Kidney function often deteriorates in patients with
MeN, and risk factors for this should be further
studied to enable preventive strategies. Comparative
studies with CKD of unknown cause in other coun-
tries are needed to elucidate whether MeN might be a
global disease, accelerated by global warming.
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